Continuous improvement of FEV <sub>1</sub> in severe eosinophilic asthmatics on anti-interleukin-5 therapy.

Auteurs

Michils A, Makhoul JP, Blekic N, Haccuria A, Perez-Bogerd S, Malinovschi A, Van Muylem A

  • Date de publication

    April 2024

  • Type

    Letter

  • Review

    Allergy

  • Researcher's name

    Perez Bogerd Silvia

  • Hôpital

    Hôpital Erasme

  • Service

    Pneumologie

  • PMID

    38659210

  • DOI

    10.1111/all.16139